SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-12-000304
Filing Date
2012-02-10
Accepted
2012-02-10 17:03:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13G sc13g107422gen_12312011.htm SC 13G/A 198842
  Complete submission text file 0000921895-12-000304.txt   200357
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 65 W WATKINS MILL RD GAITHERSBURG MD 20878
Business Address 65 W WATKINS MILL RD GAITHERSBURG MD 20878 2406320740
GENVEC INC (Subject) CIK: 0000934473 (see all company filings)

IRS No.: 232705690 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60289 | Film No.: 12593867
SIC: 2834 Pharmaceutical Preparations